C z a r n e c k i e t a l . 5 observable in Figure 4D ii vs 4E ii ). This rules out the possibility that these diffuse signals were optical 1 0 7 artifacts of metabolic signaling or stimulus-evoked movement.
1 0 8 1 0 9
Olfactory bulb interneurons respond to the omission of a learned odor 1 1 0 1 1 1
One possible function of cross-modal signaling to the olfactory bulb is to cue expectations about 1 1 2 impending odors. To test this hypothesis, naïve Gad2-GCaMP3 mice were headfixed and presented with 1 1 3 13 consecutive light-tone-odor trials (Fig. 3A) at approximately one minute intervals. The light persisted 1 1 4 for the duration of the trial with a one second tone being presented after a 3 second delay, with the odor 1 1 5 delivered immediately upon tone termination. On the 14 th trial (the test trial) the light and tone were 1 1 6 presented with same timing as on the preceding trials but the odor was omitted (Fig. 3A) . This allowed us 1 1 7 to observe the response evoked by cued expectation of an odor without presenting the odor itself.
8
Remarkably, diffuse but strong Gad2-PG activity was observed during the period the odor was expected, 1 1 9 with a peak response amplitude not significantly different from the preceding cued odor trial, even though 1 2 0 no olfactory stimulus was actually presented (Fig. 3B & E) . In a control group, the same paradigm was 1 2 1 used, but odors were never presented ( Fig. 3C ). In these mice, endogenous Gad2-PG cell responses to the 1 2 2 light and tone combination were observed (as in Fig. 1C ), but they were significantly smaller than the 1 2 3 responses to the same light and tone stimuli when they predicted an odor ( Fig. 3D & E) . The response 1 2 4 magnitude difference during odor absence in these two different trial contexts suggests that cross-modally 1 2 5 derived olfactory expectations more strongly evoke responses than repeated non-olfactory stimuli 1 2 6 containing no information regarding future olfactory consequences. Note that in this and all subsequent 1 2 7 experiments, the mice were not engaged in any behavioral task or receiving any reinforcement. 1 2 8 Fig. 3 . Expectation of odor presentation facilitates GABAergic signaling in the olfactory bulb. A) Paradigm schematic. B) Representative pseudocolor response maps of peak odor-evoked response on the final odor present trial, corresponding peak response on the following odoromitted trial, and corresponding fluorescence traces. C) Control paradigm schematic. D) Pseudocolor response maps of peak response amplitude from the six seconds following tone presentation (corresponding to the odor presentation as in A) from the 13th and 14th trials (as in B) with corresponding fluorescence traces. Note that the response maps are scaled to the same absolute values as A to illustrate the difference in response amplitude. E) Light-tone-odor GCaMP3 peak signals were significantly larger than corresponding peak responses in the light-tone only experiment (mixed model ANOVA F = 9.3, η p 2 = 0.48 from 12 mice, mean ± SE; # p < 0.02). Response amplitudes were not significantly different between the 13 th trial and 14 th trial in either paradigm.
C z a r n e c k i e t a l . 6
Odor representations are altered in response to an omitted "warning" tone 1 2 9 1 3 0 A very pure test of expectation in sensory systems is to assess whether the omission of an 1 3 1 expected cue alters the response to the stimulus the cue predicted 7 . By utilizing a sequence of predictive 1 3 2 cues like the light-tone-odor pattern presented above, we tested the effects of omission of the odor-1 3 3 predictive auditory tone cue. This allowed us to observe the neural response to the same odor, presented 1 3 4 at the same time relative to the light, with or without its directly preceding auditory cue. Naïve mice were 1 3 5 headfixed and presented with 13 consecutive light-tone cued odor trials (as in Fig. 4A ), however this 1 3 6 expectation induction phase was followed by a 14 th trial in which the light and odor were presented with 1 3 7 the same sequence and timing but the tone was omitted (Fig. 4A ). To confirm that mice detect the change 1 3 8 in stimulus contingency from the omission of the "warning tone" cue, we tested this paradigm in wild-1 3 9 type control animals while observing the mouse's pupil. When the odor was presented without the 1 4 0 expected tone cue, we observed a distinct dilation of the mouse's pupil that began shortly after odor onset 1 4 1 and was absent on the preceding three tone-present trials (Fig. 4B ). When the experiment was repeated in 1 4 2
Gad2-GCaMP3 mice, on the tone-omitted trial the presentation of the odor evoked a significantly larger 1 4 3 response ( Fig. 4D i-iv ) during the first odor inhalation than on the preceding tone-present trial. 1 4 4
Fig. 4. Expectation violation facilitates GABAergic signaling and suppresses presynaptic calcium in OSNs in the olfactory bulb. A) Paradigm schematic. B)
Odor-evoked pupillary response shows pupil dilation on the tone omitted trial compared to the average of the previous three tone-present trials. Cii & Ciii) Representative pixel-by-pixel difference maps of odorant-evoked GCaMP3 (left) and Calcium Green (right) signals on the first peak of the last tone-present trial and first tone-omitted trial. Red indicates increase on the tone-omitted trial while blue indicates decrease. Di&Dii) Pseudocolor maps and fluorescence traces of odorant-evoked calcium signaling in GAD65-PG cell populations during tone-present (left/black) and tone-omitted (right/red) odorant presentations (green bar). Diii&Div) C z a r n e c k i e t a l . 7
Odorant-evoked intraglomerular GCaMP3 signals were significantly larger on first inhalation of tone omitted (red) trials than on preceding tone-present trials (black), as shown in cumulative frequency distributions (Diii; Wilcoxon Signed Ranks Test Z = -8.56, average first sniff odorant-evoked fluorescence in inlay) and Change Index (CI) (Div; t(136) = -11.33, mean ± SE, paired t-test) across 137 glomeruli from 5 mice ** p < 0.01. Ei&Eii) Analogous maps and traces to Di & Dii but of presynaptic calcium signaling in OSN terminals. Eiii&Eiv) Odorant-evoked intraglomerular Calcium Green signals were significantly smaller on first inhalation of tone omitted (red) trials than on preceding tone-present trials (black), as shown in cumulative frequency distribution (Eiii; Wilcoxon Signed Ranks Test Z = -3.86, average first sniff odorant-evoked fluorescence in inlay) and CI (Eiv; t(21) = 4.29, mean ± SE, paired t-test) across 22 glomeruli from 4 mice.
4 5
Since GABA released from Gad2-PG cells binds to GABA B receptors on the presynaptic 1 4 6 terminals of OSNs, suppresses N-type calcium conductance and thus neurotransmitter release 25 , we 1 4 7
hypothesized that the increased response of Gad2-PG cells on the first inhalation of an odor presented 1 4 8 1 6 8 present trial ( Fig. 5A-C) . Notably, the odor responses were not different between tone-present and tone-1 6 9
omitted trials during the baseline trials, demonstrating that the mere presence of a tone that does not 1 7 0 strongly correlate with odor presentation had no effect on OSN output ( Fig. 5C ). Finally, to confirm the with the finding that cross-modal information does not reach the PG-OSN circuit in anesthetized mice.
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Fig. 5. No effect of expectation when tone omission is not surprising, or in anesthetized animals. A) Low surprise paradigm schematic. B)
Pseudocolor maps of odorant-evoked fluorescence on the first sniff of the last tone present trial (left) and first tone omitted trial (right). C) No difference (mean ± SE, paired samples t-test, t(19) = -0.9, p = 0.38); scaled JZS Bayes Factor = 3.0 in response to odorant on tone-present and tone-omitted trials (Violation). During induction phase, average of last 3 tonepresent (grey) and last 3 tone-omitted (dark red) trials was not different (paired samples t-test t(20) = -1.01, p = 0.33; scaled JZS Bayes Factor = 2.8). D) High surprise paradigm. E&G) Analogous pseudocolor maps and CI measurements to B and C but in anesthetized OMP-spH mice. No difference in response amplitudes between the tone-omitted trial and preceding tone-present trial (F, Wilcoxon Z = -0.13; G, mean ± SE, paired samples t-test t(59) = 1.72, p = 0.09, scaled JZS Bayes Factor = 1.77, 60 glomeruli from 4 mice). omitted test trial did not evoke less neurotransmitter release from OSNs than odor presentation on the 1 9 0 preceding tone-present trial in mice that received CGP35348 ( Fig. 6E & G, right), consistent with the 1 9 1 hypothesis that the reduced OSN synaptic output on tone-omitted trials is caused by GABA B receptor 1 9 2 activation. Control mice receiving CGP35348 infusion did exhibit expected differences in pupillary 1 9 3 diameter on tone-omitted trials, confirming that they detected the omission of the tone (Fig. S2 ). OMP-1 9 4 spH mice that received vehicle infusion showed no significant effect of infusion and did show the 1 9 5
expected reduction in OSN output on the tone-omitted test trial ( Fig. 6H -J). While it may seem 1 9 6 counterintuitive for the olfactory system to suppress OSN neurotransmitter release when an odor is 1 9 7
presented unexpectedly, in fact the suppression of glutamate release via presynaptic GABA B receptors 1 9 8
can potentially help prevent neurotransmitter depletion and AMPA receptor desensitization, thus 1 9 9
increasing the synapses' ability to sustain activity during periods of strong stimulation 12, 27, 30, 31 .
2 0 0 2 0 1
Fig. 5. Expectation violation suppresses neurotransmitter release from OSNs via GABA B receptormediated presynaptic inhibition. A)
Pseudocolor maps of odorant-evoked fluorescence on last tonepresent trial (left) and tone omitted trial (right) in OBs of an awake OMP-spH mouse. B&C) Odorantevoked spH signals on tone-omitted (red) trials were significantly smaller than on preceding tonepresent trials (black), as shown in cumulative frequency distributions (B; Wilcoxon Signed Ranks Test Z = -4.78) and Change Index (C; paired t(37) = 8.17) across 38 glomeruli from 5 mice. ** p < 0.01 D) Representative pixel-by-pixel difference map of odorant-evoked fluorescence on last tone-present trial C z a r n e c k i e t a l . 1 0 and following tone-omitted trial. Blue indicates suppression on tone-omitted trial. E&H) Pseudocolor maps of odorant-evoked fluorescence on baseline tone-present trial, post-infusion tone-present trial, and post-infusion tone-omitted trial after GABA B antagonist or vehicle infusion. F&G) GABA B receptor blockade significantly enlarged odorant-evoked spH signals on last three tone present pre-infusion trials compared to last three tone present post-infusion trials (F; mean ± SE, paired t(70) = -7.61; 71 glomeruli from 4 mice). Vehicle infusion did not (I; t(53) = -1.84, 54 glomeruli from 5 mice; scaled JZS Bayes Factor = 1.4). G) After GABA B receptor blockade, odorant-evoked spH signals on tone-omitted trials (red) were no different than preceding tone-present trials (black) (paired t(67) = -1.33; scaled JZS Bayes Factor = 3.24). J) After vehicle infusion, odorant-evoked spH signals on tone-omitted trial (red) were significantly smaller than on tone-present trials (black) (paired t(53) = 7.67).
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Materials and Methods
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Subjects 2 3 0
A total of 73 mice were used in these experiments of which 36 were male and 37 were female.
3 1
All mice were between 2 and 10 months of age the time of experimentation. The fluorescent calcium 2 3 2
indicator GCaMP3 Headcaps and cranial windows were implanted as previously reported 45, 46 . Briefly, mice were 2 5 2 anesthetized with 1000 µg/kg dexmedetomadine (Dexdomitor, Orion Corporation) and 70 mg/kg 2 5 3 ketamine administered i.p. with bupivicaine (~0.25 mL at 0.25%, s.c.) as a local anesthetic at the incision 2 5 4 site. The scalp was shaved, washed with three cycles of Betadine and 70% ethanol and then surgically 2 5 5 opened with a midline incision. The periosteal membrane was removed and the skull dried with a 70% 2 5 6 ethanol solution. A custom acrylic headcap was secured using cyanoacrylate and dental acrylic and the 2 5 7 skull overlying both olfactory bulbs was thinned to transparency and coated with a thin layer of 2 5 8 cyanoacrylate. The wound margins were secured with tissue adhesive (Vetbond, 3M) and the window 2 5 9 covered by a protective metal shield secured to the headcap. For calcium imaging OSNs were loaded with 2 6 0 4 µL 4% Calcium Green dextran potassium salt, a dextran-conjugated, fluorescent calcium-sensitive dye 2 6 1 (Life Technologies, Grand Island, NY) by intranasal instillation during headcap implantation after the 2 6 2 manner of Wachowiak and Cohen 26 . Briefly, a microloader attached to a Hamilton syringe was inserted 2 6 3 7mm into each naris. The animal was rotated onto its back and 2 µL 2% Triton was instilled initially 2 6 4 followed by 2 µL 4% Calcium Green after 1 min. The remaining 2µL was instilled 5 min later. After an 2 6 5 additional 5 min the animal was rotated onto its side to allow the dye to reach all areas of the epithelium.
6 6
The same procedure was performed on the contralateral side after an additional 15 min. Anesthesia was 2 6 7 reversed with 1 mg/kg s.c. atipamezole (Antisedan, Orion Corporation). Mice were given 24-48 hours 2 6 8 recovery time prior to further experimentation. All animals were singly housed following headcap 2 6 9 implantation. 
0 7
Auditory stimuli were matched for position and sound pressure level. Two mice were excluded from 3 0 8 analysis because the pupil was frequently obscured by partial closure of the lower eyelid, but exhibited 3 0 9
qualitatively similar behavior to those reported here. An additional mouse was excluded because its pupil 3 1 0 was completely dilated and exhibited no pupillary responses to any stimulus, suggesting a ceiling effect.
1 1
To improve signal-to-noise ratio, the average of the final three tone-present trials was calculated as a 3 1 2 baseline for each mouse. Data were normalized for averaging across mice. into an S-shape, and pulled and PE-50 tubing (Scientific Commodities, Inc) was pulled and secured onto 3 1 7 the glass capillary tube in order to extend the opening of the capillary tube away from the thoracic cavity.
1 8
Following cranial window implantation, mice were placed on their back and given bupivicane along the condensation and cleared when necessary.
2 8
Drug administration via intraperitoneal cannula 3 2 9
Mice were randomly assigned to receive either saline or CGP35348 infusions. Animals were 3 3 0 lightly anesthetized with isoflurane (Aerrane, Baxter Healthcare, Deerfield, IL) and implanted with a pre- response on the test and reference trials are the same size, and asymptotically approaches 1 as the 3 5 3 response on the test trials exceeds the reference trial. This approach is superior to traditional "percent 3 5 4 change" approaches because it prevents unidirectional bounding, i.e. that responses can be more than 3 5 5 100% increased but cannot be more than 100% decreased. Pilot experiments were used to assess approximate power utilizing these within-subjects designs.
5 8
We have generally presented both normalized group data (with appropriate parametric statistics) as well 3 5 9
as distributions (and appropriate non-parametric statistics of raw values) of all data points that went into 3 6 0 the parametric group averages. Paired samples t-tests were used for planned comparisons within-subjects 3 6 1 between two trial types. Wilcoxon Signed Rank tests were used for analyses of related distributions.
6 2
Mixed model ANOVAs were used for designs with within and between subjects manipulations except for 3 6 3 modality comparisons in figure 1. In this case, all subjects did not receive all stimuli, thus not allowing 3 6 4 for complete matched cases. Instead, a Mixed Linear Model was used. All tests were two-tailed. One Comparison of GCaMP3 expression to OSN afferents (Fig. 1B) 3 7 1
OSNs were labeled with AlexaFluor 568-conjugated dextran (Life Technologies) via intranasal 3 7 2 infusion as described above. GCaMP3 was expressed in via cre recombinase-mediated excision of a 3 7 3 floxed STOP codon in cells expressing cre recombinase from the gad2 locus as described in the main text.
7 4
Structural images were captured through a cranial window in anesthetized mice using a 2-photon 3 7 5 microscope (Neurolabware) with a 25X objective with a 1.05 numerical aperture (Nikon). o  t  h  e  r  m  e  l  ,  M  .  ,  C  a  r  e  y  ,  R  .  M  .  ,  P  u  c  h  e  ,  A  .  ,  S  h  i  p  l  e  y  ,  M  .  T  .  &  W  a  c  h  o  w  i  a  k  ,  M  .  C  h  o  l  i  n  e  r  g  i  c  i  n  p  u  t  s  f  r  o  m  4  2  4  B  a  s  a  l  f  o  r  e  b  r  a  i  n  a  d  d  a  n  e  x  c  i  t  a  t  o  r  y  b  i  a  s  t  o  o  d  o  r  c  o  d  i  n  g  i  n  t  h  e  o  l  f  a  c  t  o  r  y  b  u  l  b  .   T  h  e  J  o  u  r  n  a  l  o  f   4  2  5   n  e  u  r  o  s  c  i  e  n  c  e  :  t  h  e  o  f  f  i  c  i  a  l  j  o  u  r  n  a  l  o  f  t  h  e  S  o  c  i  e  t  y  f  o  r  N  e  u  r  o  s  c  i  e  n  c  e   3  4   ,  4  6  5  4  -4  6  6  4  ,  4  2  6  d  o  i  :  1  0  .  1  5  2  3  /  J  N  E  U  R  O  S  C  I  .  5  0  2  6  -1  3  .  2  0  1  4  (  2  0  1 
